Nano Targeting & Therapy (NTT) Biopharma Inc. is an innovative biotech company developing silica nanocarrier platforms designed to successfully optimize drug delivery substances through patented mesoporous silica nanoparticle (MSN) technology. Our aim is to develop nanomedicine products for therapies in diseases with complex drug delivery issues like brain cancer, immunotherapies, and ocular diseases.
NTT Biopharma has its own pipeline of nano-formulated NCE/505(b)(2) products, and we also aim to partner with pharmaceutical companies seeking better solutions for drug delivery. We provide the contract research services for novel formulation development, manufacturing process optimization, supply at the non-GMP quality level, and preliminary efficacy evaluation studies. We can also be a long-term partner in the drug development process.
Nano Targeting & Therapy (NTT) Biopharma Inc. is an innovative biotech company developing silica nan…
more...Nano Targeting & Therapy (NTT) Biopharma Inc. is an innovative biotech company developing silica nan…
more...詹维康
董事长
吴政勳
营运长